The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The updates prompted London-based Airfinity to cut its forecast for the U.S. RSV vaccine market by 64% to $1.7B from $4.7B a year to reflect the revised guidance, which, it said, reduced the ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. Adults ages 75 and older should get a single dose of an RSV vaccine, the CDC says. Younger ...

Studies presented to the CDC ACIP Work Group for RSV found both vaccines from fall 2023 may result in a slightly elevated risk of Guillain-Barré syndrome, a rare but serious condition.

RSV sent fewer babies to the hospital last winter, after new treatment and vaccine arrived New tools may have reduced cases of severe respiratory illness, CDC says Manage alerts for this article ...

RSV is a respiratory infection, most common in young children and newborns. Albany (GA) WALB. CDC reports peak in RSV cases, ... cold-like symptoms, in the form of a runny nose, congestion ...

The CDC says that, yearly, RSV leads to 58,000–80,000 hospitalizations among children younger than 5 years old and 100,000–150,000 hospitalizations among adults 60 years and older.